ClinicalTrials.Veeva

Menu

Characterization of Methylation Patterns in Lung Cancer

N

Nucleix

Status

Completed

Conditions

Lung Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT02373917
Lung-RND-001

Details and patient eligibility

About

In this study the investigators will collect Blood,sputum and saliva samples for Characterization of Methylation Patterns in lung Cancer.

Full description

Lots of information about the relationship between changes in methylation patterns and various diseases are accumulated in recent years. Characterization of methylation changes that occur in cancer may contribute to the development of methods for early detection of cancer by detecting cancer cells in liquids. Early detection of such changes and their correlation examining different cancers may lead to a diagnostic tool for the early detection of cancers and improve the treatment of these patients. Detection by molecular analysis can be a sensitive method and non-invasive early diagnosis of the disease In this study the investigators will collect Blood,sputum and saliva samples for Characterization of Methylation Patterns in lung Cancer.

Enrollment

683 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with suspected lung tumor

Exclusion criteria

  • Patients who have active disease other than lung cancer during the sample collecting

Trial design

683 participants in 2 patient groups

study group
Description:
patient who in the biopsy showed lung cancer
control group
Description:
patient who in the biopsy showed not to have lung cancer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems